55
In band
Moving averages
SMA 200$0.98-59.08%
Company profile
Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States. The company is headquartered in Princeton, New Jersey.
SectorHealthcare
IndustryBiotechnology
Market cap$8.71M
P/E ratioNone
EPS$-0.72
Beta1.921
Dividend yield0.00%
52-week high$6.23
52-week low$0.28
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 79
VRTX
Vertex Pharmaceuticals Inc
RSI 67
CRSP
CRISPR Therapeutics AG
RSI 67
IOVA
Iovance Biotherapeutics Inc
RSI 72
MRNA
Moderna Inc
RSI 72
VKTX
Viking Therapeutics Inc
RSI 48
SRPT
Sarepta Therapeutics Inc
RSI 59
EDIT
Editas Medicine Inc
RSI 57
NVAX
Novavax Inc
RSI 63
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 46
RSI alerts for SNGX
Get an email the moment Soligenix Inc. crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 16 August 2026 at 12:59 AM EDT